HARMONY BIOSCIENCES HOLDINGS, INC. Basic Shares Outstanding (Weighted Average)
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Basic Shares Outstanding (Weighted Average) of 57.93 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 57.93M shares, a 0.81% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 57.82M shares, a 0.89% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 57.00M shares, a 0.16% decline year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 57.55M shares, a 1.20% increase year-over-year.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 57.49M shares, a 1.07% increase from fiscal 2024.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 56.89M shares, a 4.35% decline from fiscal 2023.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 59.47M shares, a 0.50% increase from fiscal 2022.
- HARMONY BIOSCIENCES HOLDINGS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 59.17M shares, a 2.85% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 57.93M shares 10-Q · filed 2026-08-04 | 57.88M shares 10-Q · filed 2026-08-04 | 57.59M shares derived: average of 3 quarters · filed 2026-08-04 | 57.58M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 57.82M shares 10-Q · filed 2026-05-07 | 57.41M shares derived: average of 2 quarters · filed 2026-05-07 | 57.46M shares derived: average of 3 quarters · filed 2026-05-07 | 57.46M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 57.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 57.28M shares derived: average of 2 quarters · filed 2026-02-24 | 57.34M shares derived: average of 3 quarters · filed 2026-08-04 | 57.49M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 57.55M shares 10-Q · filed 2025-11-04 | 57.51M shares derived: average of 2 quarters · filed 2026-08-04 | 57.66M shares 10-Q · filed 2025-11-04 | 57.36M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 57.47M shares 10-Q · filed 2026-08-04 | 57.39M shares 10-Q · filed 2026-08-04 | 57.29M shares derived: average of 3 quarters · filed 2026-08-04 | 57.19M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 57.31M shares 10-Q · filed 2026-05-07 | 57.20M shares derived: average of 2 quarters · filed 2026-05-07 | 57.09M shares derived: average of 3 quarters · filed 2026-05-07 | 57.02M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 57.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 56.98M shares derived: average of 2 quarters · filed 2026-02-24 | 56.92M shares derived: average of 3 quarters · filed 2026-02-24 | 56.89M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 56.87M shares 10-Q · filed 2025-11-04 | 56.84M shares derived: average of 2 quarters · filed 2025-11-04 | 56.82M shares 10-Q · filed 2025-11-04 | 57.19M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 56.80M shares 10-Q · filed 2025-08-05 | 56.79M shares 10-Q · filed 2025-08-05 | 57.29M shares derived: average of 3 quarters · filed 2026-02-24 | 57.94M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 56.77M shares 10-Q · filed 2025-05-06 | 57.54M shares derived: average of 2 quarters · filed 2026-02-24 | 58.31M shares derived: average of 3 quarters · filed 2026-02-24 | 58.73M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 58.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 59.09M shares derived: average of 2 quarters · filed 2026-02-24 | 59.38M shares derived: average of 3 quarters · filed 2026-02-24 | 59.47M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 59.86M shares 10-Q · filed 2024-10-29 | 59.92M shares derived: average of 2 quarters · filed 2024-10-29 | 59.86M shares 10-Q · filed 2024-10-29 | 59.76M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 59.97M shares 10-Q · filed 2024-08-06 | 59.85M shares 10-Q · filed 2024-08-06 | 59.73M shares derived: average of 3 quarters · filed 2025-02-25 | 59.61M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 59.73M shares 10-Q · filed 2024-04-30 | 59.61M shares derived: average of 2 quarters · filed 2025-02-25 | 59.48M shares derived: average of 3 quarters · filed 2025-02-25 | 59.38M shares derived: average of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 59.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 59.36M shares derived: average of 2 quarters · filed 2025-02-25 | 59.26M shares derived: average of 3 quarters · filed 2025-02-25 | 59.17M shares 10-K · filed 2025-02-25 |
| 2022-09-30 | 59.23M shares 10-Q · filed 2023-10-31 | 59.15M shares derived: average of 2 quarters · filed 2023-10-31 | 59.07M shares 10-Q · filed 2023-10-31 | 58.94M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 59.06M shares 10-Q · filed 2023-08-01 | 58.99M shares 10-Q · filed 2023-08-01 | 58.84M shares derived: average of 3 quarters · filed 2024-02-22 | 58.56M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 58.91M shares 10-Q · filed 2023-05-02 | 58.74M shares derived: average of 2 quarters · filed 2024-02-22 | 58.40M shares derived: average of 3 quarters · filed 2024-02-22 | 58.03M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | 58.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 58.14M shares derived: average of 2 quarters · filed 2024-02-22 | 57.74M shares derived: average of 3 quarters · filed 2024-02-22 | 57.53M shares 10-K · filed 2024-02-22 |
| 2021-09-30 | 57.72M shares 10-Q · filed 2022-11-01 | 57.33M shares derived: average of 2 quarters · filed 2022-11-01 | 57.19M shares 10-Q · filed 2022-11-01 | 57.17M shares derived: average of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | 56.94M shares 10-Q · filed 2022-08-02 | 56.92M shares 10-Q · filed 2022-08-02 | 56.98M shares derived: average of 3 quarters · filed 2023-02-21 | 50.29M shares derived: average of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | 56.89M shares 10-Q · filed 2022-05-03 | 57.00M shares derived: average of 2 quarters · filed 2023-02-21 | 48.07M shares derived: average of 3 quarters · filed 2023-02-21 | 38.01M shares derived: average of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | 57.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | 43.66M shares derived: average of 2 quarters · filed 2023-02-21 | 31.71M shares derived: average of 3 quarters · filed 2023-02-21 | 25.77M shares 10-K · filed 2023-02-21 |
| 2020-09-30 | 30.21M shares 10-Q · filed 2021-11-09 | 19.01M shares derived: average of 2 quarters · filed 2021-11-09 | 15.32M shares 10-Q · filed 2021-11-09 | 13.40M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 7.81M shares 10-Q · filed 2021-08-10 | 7.80M shares 10-Q · filed 2021-08-10 | 7.79M shares derived: average of 3 quarters · filed 2022-02-28 | 7.79M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 7.79M shares 10-Q · filed 2021-05-11 | 7.78M shares derived: average of 2 quarters · filed 2022-02-28 | 7.78M shares derived: average of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | 7.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 7.78M shares derived: average of 2 quarters · filed 2022-02-28 | 7.78M shares 10-K · filed 2022-02-28 | |
| 2019-09-30 | 7.78M shares 10-Q · filed 2020-11-12 | 7.78M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |